These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6617438)

  • 1. [Congenital malaria and seroconversion following anti-measles vaccination].
    Diallo S; Denis F; Ndir O; Victorius A
    Dakar Med; 1983; 28(1):143-7. PubMed ID: 6617438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-measles vaccination and malaria].
    Richard-Lenoble D; Kombila M; Guillemot O; Guillemot F; Monjour L; Gendrel D
    Arch Fr Pediatr; 1987 Nov; 44(9):817-9. PubMed ID: 3328577
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroconversion following measles immunisation.
    Mittal SK; Gulati A; Kumari P; Bala V; Gupta S
    Indian Pediatr; 1979 Apr; 16(4):309-11. PubMed ID: 511301
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age.
    Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal antibody inhibits both cellular and humoral immunity in response to measles vaccination at birth.
    Premenko-Lanier M; Hodge G; Rota P; Tamin A; Bellini W; McChesney M
    Virology; 2006 Jul; 350(2):429-32. PubMed ID: 16569419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to measles vaccine in 6 month old infants in Papua New Guinea.
    Kurubi J; Vince J; Ripa P; Tefuarani N; Riddell M; Duke T
    Trop Med Int Health; 2009 Feb; 14(2):167-73. PubMed ID: 19171008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles vaccination during the respiratory virus season and risk of vaccine failure.
    Edmonson MB; Davis JP; Hopfensperger DJ; Berg JL; Payton LA
    Pediatrics; 1996 Nov; 98(5):905-10. PubMed ID: 8909484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to measles vaccine in Peruvian children.
    Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
    Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine.
    Isozaki M; Kuno-Sakai H; Hoshi N; Takesue R; Takakura I; Kimura M; Hikino M; Mitsuda M
    Tokai J Exp Clin Med; 1982 Sep; 7(5):547-50. PubMed ID: 7182947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P; Branciaroli A; Di Battista S; Di Filippo A; Di Pietro M; Calafiore P; Di Battista C
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to measles immunization and the impacts on HIV-infected children.
    Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atopic eczema with generalized lymph node swelling and deficient antibody formation despite repeat vaccination with live vaccines (measles, mumps)--atypical vaccination reaction, vaccination damage or vaccination failure?].
    Wiersbitzky S; Peters A; Bruns R; Pambor M
    Kinderarztl Prax; 1993 Feb; 61(1):34-6. PubMed ID: 8464197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.